FrançaisMovember

In The News

Prostate Cancer Awareness Day at BC Legislative Assembly
VICTORIA, May 4, 2012- On Monday, May 7, Prostate Cancer Canada (PCC) will host their first Legislative Assembly Day to promote education and awareness of prostate cancer in British Columbia.

Media Advisory - Prostate Cancer Canada celebrates local Halifax hero
HALIFAX, April 25, 2012 /CNW/ - Please join Prostate Cancer Canada and members of the Halifax business community as we celebrate a local hero who has made an extraordinary contribution in the fight against prostate cancer through courage, inspiration and dedication.

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.


Prostate Cancer News

In the past few years more and more discoveries regarding prostate cancer testing, diagnosis, treatment options have been discovered. Please read through this section of our website to learn more about the latest discoveries relating to prostate cancer.


Displaying results 1-5 (of 48)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 
Health Canada releases advisory on drugs finasteride and dutasteride | 3/20/2012
Health Canada recently released an advisory to the public and health professionals about prescription drugs finasteride and dutasteride. These drugs are part of a class of drugs known as 5 alpha reductase inhibitors and have been shown in two large international clinical trials to reduce the likelihood of being diagnosed with prostate cancer.


Important news about Vitamin E and prostate cancer  | 12/6/2011
It was recently published in the Journal of the American Medical Association (JAMA)  that  the “SELECT Trial” for prostate cancer prevention with oral Vitamin E and selenium supplementation, alone or In combination, compared to placebo, was negative i.e. there was no benefit with the supplements in terms of prostate cancer prevention.


PCC position on PSA testing | 11/2/2011
The United States Preventive Services Task Force (USPSTF) has recently recommended against the use of prostate specific antigen (PSA) to screen for prostate cancer in asymptomatic men. In light of this development, Prostate Cancer Canada (PCC) wishes to clarify its position on PSA testing. PCC continues to support and recommend PSA testing for the early detection of prostate cancer.    PCC emphasizes that, applied appropriately, PSA is a useful test.  A full discussion with the patient on the pros and cons of PSA testing should continue to be an integral part of patient management.     


A made-in-Canada view of PSA testing | 10/25/2011
A“tizzy” is perhaps the best way to describe the effects of the recommendation released earlier this month by the United States Preventive Services Task Force, a panel of medical professionals that provides guidance on preventive health measures. The recommendation concerned the prostate-specific antigen (PSA) test, which is conducted on men to screen for cancer of the prostate gland, the most common form of cancer experienced by Canadian men.
While no one disputes the PSA test helps to detect cancer, the task force decided on the basis of five large clinical trials that the risks of prostate cancer treatment outweighed the risks of prostate cancer itself. In other words, the task force was telling healthy men they were better off not knowing whether they had prostate cancer.


Early Detection Guidelines Update | 10/6/2011
Prostate Cancer Canada (PCC) strongly believes in the merits of screening for prostate cancer and actively encourages all men over the age of 40 to have the prostate cancer discussion with their doctor and begin PSA (Prostate Specific Antigen) testing.
Displaying results 1-5 (of 48)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 
RT @mheavyarmour: proud to announce we've met our group goal for @ProstateCancerC - not done yet, this is just motivation to do better!
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325

Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital